(Q51252316)

2 April 2018

title

Coinoculation with hepatitis B surface and core antigen promotes a Th1 immune response to a multiepitopic protein of HIV-1. (English)

1 reference

2 April 2018

1

Enrique Iglesias

1 reference

2 April 2018

author name string

Rafael Thompson

2

1 reference

2 April 2018

Yamilka Carrazana

3

1 reference

2 April 2018

Yadira Lobaina

4

1 reference

2 April 2018

Daymir García

5

1 reference

2 April 2018

Jorge Sánchez

6

1 reference

2 April 2018

José García

7

1 reference

2 April 2018

Otto Cruz

8

1 reference

2 April 2018

Emma Brown

9

1 reference

2 April 2018

Alejandro Martin

10

1 reference

2 April 2018

Verena L Muzio

11

1 reference

2 April 2018

Julio C Aguilar

12

1 reference

2 April 2018

publication date

1 April 2006

1 reference

2 April 2018

Immunology & Cell Biology

published in

1 reference

2 April 2018

volume

84

1 reference

2 April 2018

issue

2

1 reference

2 April 2018

page(s)

174-183

1 reference

2 April 2018

Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

High HIV-1 genetic diversity in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus: no evidence of faster progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Hepatitis B immunization of newborns according to a two dose protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Immune response to hepatitis B virus proteins: relevance of the murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

The core antigen of hepatitis B virus as a carrier for immunogenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Immunopathogenesis and immunotherapy in AIDS virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Induction of antigen-specific CTL responses using antigens conjugated to short peptide vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Binding immune-stimulating oligonucleotides to cationic peptides from viral core antigen enhances their potency as adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Inhibition of HIV-1 rgp120 binding to CD4+ T cells by monoclonal antibodies directed against the gp120 C1 or C4 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

The Th1-Th2 hypothesis of HIV infection: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Aluminium compounds for use in vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2005.01408.X

10.1111/J.1440-1711.2005.01408.X

21 January 2018

Identifiers

DOI

1 reference

2 April 2018

1 reference

2 April 2018